Cargando…
SHP2 allosteric inhibitor TK-453 alleviates psoriasis-like skin inflammation in mice via inhibition of IL-23/Th17 axis
SHP2 is the first oncogenic tyrosine phosphatase encoded by PTPN11, which plays a significant regulatory role in cancer and inflammation-related diseases. Although SHP2 allosteric inhibitors have been used in phase I/II clinical trials for solid tumors, whether SHP2 inhibition alleviates psoriasis r...
Autores principales: | Wang, Meijing, Li, Tinghan, Ouyang, Zijun, Tang, Kai, Zhu, Yuyu, Song, Chenglin, Sun, Haiyan, Yu, Bin, Ji, Xiaoyun, Sun, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927994/ https://www.ncbi.nlm.nih.gov/pubmed/35310939 http://dx.doi.org/10.1016/j.isci.2022.104009 |
Ejemplares similares
-
Tyrosine phosphatase SHP2 exacerbates psoriasis‐like skin inflammation in mice via ERK5‐dependent NETosis
por: Ding, Yan, et al.
Publicado: (2022) -
Allosteric inhibition of SHP2 uncovers aberrant TLR7 trafficking in aggravating psoriasis
por: Zhu, Yuyu, et al.
Publicado: (2021) -
SHP2-mediated mitophagy boosted by lovastatin in neuronal cells alleviates parkinsonism in mice
por: Liu, Wen, et al.
Publicado: (2021) -
Selective inhibition of leukemia-associated SHP2(E69K) mutant by the allosteric SHP2 inhibitor SHP099
por: Sun, X, et al.
Publicado: (2018) -
Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors
por: Franciosa, Giulia, et al.
Publicado: (2023)